ACETO Board of Directors Declares Quarterly Cash Dividend Read more about ACETO Board of Directors Declares Quarterly Cash Dividend
ACETO Reports Fiscal 2018 First Quarter Results Read more about ACETO Reports Fiscal 2018 First Quarter Results
ACETO Subsidiary, Rising Pharmaceuticals, Launches Sertraline Oral Solution, 20mg/ml Read more about ACETO Subsidiary, Rising Pharmaceuticals, Launches Sertraline Oral Solution, 20mg/ml
ACETO Corporation Schedules First Quarter Fiscal 2018 Financial Results News Release and Conference Call Read more about ACETO Corporation Schedules First Quarter Fiscal 2018 Financial Results News Release and Conference Call
ACETO Appoints William C. Kennally, III President and CEO Read more about ACETO Appoints William C. Kennally, III President and CEO
ACETO to Present at the Morgan Stanley 15th Annual Global Healthcare Conference Read more about ACETO to Present at the Morgan Stanley 15th Annual Global Healthcare Conference
ACETO Reports Fiscal 2017 Fourth Quarter and Full Year Results Read more about ACETO Reports Fiscal 2017 Fourth Quarter and Full Year Results
ACETO Board of Directors Declares Quarterly Cash Dividend Read more about ACETO Board of Directors Declares Quarterly Cash Dividend
ACETO Corporation Schedules Fourth Quarter & Fiscal 2017 Financial Results News Release and Conference Call Read more about ACETO Corporation Schedules Fourth Quarter & Fiscal 2017 Financial Results News Release and Conference Call
> Investors > 
